Cargando…

VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients

BACKGROUND: Radical surgical resection of the primary tumor with mono/bilateral inguinofemoral lymph node dissection is the standard treatment for invasive vulvar squamous cell carcinoma (VSCC) and is frequently related to severe morbidity. Tailoring surgical treatment is of paramount importance, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravaggi, Antonella, Gambino, Angela, Ferrari, Federico, Olivari, Alessandro, Zanotti, Laura, Romani, Chiara, Ardighieri, Laura, Antonelli, Paolo, Garganese, Giorgia, Gallo, Daniela, Scambia, Giovanni, Bignotti, Eliana, Sartori, Enrico, Calza, Stefano, Odicino, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026339/ https://www.ncbi.nlm.nih.gov/pubmed/35463308 http://dx.doi.org/10.3389/fonc.2022.818613

Ejemplares similares

Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma
por: Ravaggi, Antonella, et al.
Publicado: (2022)

Identification of stably expressed reference small non‐coding RNAs for microRNA quantification in high‐grade serous ovarian carcinoma tissues
por: Bignotti, Eliana, et al.
Publicado: (2016)

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients
por: Bignotti, Eliana, et al.
Publicado: (2020)

RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients
por: Vezzoli, Marika, et al.
Publicado: (2017)

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2019)

Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
por: Romani, Chiara, et al.
Publicado: (2020)

The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
por: Romani, Chiara, et al.
Publicado: (2021)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
por: Zanotti, Laura, et al.
Publicado: (2017)

L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma
por: Romani, Chiara, et al.
Publicado: (2022)

Identification of Optimal Reference Genes for Gene Expression Normalization in a Wide Cohort of Endometrioid Endometrial Carcinoma Tissues
por: Romani, Chiara, et al.
Publicado: (2014)

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes
por: Ardighieri, Laura, et al.
Publicado: (2021)

The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines
por: Bandiera, Elisabetta, et al.
Publicado: (2016)

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence
por: Tassi, Renata A, et al.
Publicado: (2009)

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery
por: Romani, Chiara, et al.
Publicado: (2015)

Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Todeschini, Paola, et al.
Publicado: (2021)

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2017)

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma
por: Bignotti, Eliana, et al.
Publicado: (2012)

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
por: Bignotti, E, et al.
Publicado: (2011)

Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways
por: Romani, Chiara, et al.
Publicado: (2023)

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
por: Bignotti, E, et al.
Publicado: (2008)

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis
por: Bignotti, Eliana, et al.
Publicado: (2013)

The Role of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: A Systematic Review and Meta-Analysis
por: Verri, Debora, et al.
Publicado: (2022)

Surgical therapy of vulvar cancer: how to choose the correct reconstruction?
por: Gentileschi, Stefano, et al.
Publicado: (2016)

Endometrial Carcinomas with Intestinal-Type Metaplasia/Differentiation: Does Mismatch Repair System Defects Matter? Case Report and Systematic Review of the Literature
por: Ardighieri, Laura, et al.
Publicado: (2020)

Secondary post-oncologic vulvar reconstruction – a simplified algorithm
por: Caretto, Anna Amelia, et al.
Publicado: (2023)

The Vulvar Immunohistochemical Panel (VIP) Project: Molecular Profiles of Vulvar Squamous Cell Carcinoma
por: Garganese, Giorgia, et al.
Publicado: (2021)

Current Treatment Options for Cervical Leiomyomas: A Systematic Review of Literature
por: Ferrari, Federico, et al.
Publicado: (2021)

Evaluating the Risk of Inguinal Lymph Node Metastases before Surgery Using the Morphonode Predictive Model: A Prospective Diagnostic Study in Vulvar Cancer Patients
por: Fragomeni, Simona Maria, et al.
Publicado: (2023)

Diagnostic performance of preoperative [(18)F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study
por: Rufini, Vittoria, et al.
Publicado: (2021)

Impact of endometrial sampling technique and biopsy volume on the diagnostic accuracy of endometrial cancer
por: Ferrari, Federico, et al.
Publicado: (2020)

Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets
por: Romani, Chiara, et al.
Publicado: (2021)

Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial
por: Gurizzan, Cristina, et al.
Publicado: (2021)

MRI in the Evaluation of Locally Advanced Vulvar Cancer Treated with Chemoradiotherapy and Vulvar Cancer Recurrence: The 2021 Revision of FIGO Classification and the Need for Multidisciplinary Management
por: Miccò, Maura, et al.
Publicado: (2022)

Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma
por: Romani, Chiara, et al.
Publicado: (2021)

Solitary pancreatic lymph node metastasis from carcinoma of the breast: case report
por: Corrado, Giacomo, et al.
Publicado: (2010)

Claudin3 is localized outside the tight junctions in human carcinomas
por: Corsini, Michela, et al.
Publicado: (2018)

Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT
por: Garganese, Giorgia, et al.
Publicado: (2020)

Gov➔Value: How to combine reported quality experiences and patient-reported outcome measures. First results on vulvar cancer patients in an Italian Research Hospital
por: de Mattia, Egidio, et al.
Publicado: (2022)

MRI Staging in Locally Advanced Vulvar Cancer: From Anatomy to Clinico-Radiological Findings. A Multidisciplinary VulCan Team Point of View
por: Gui, Benedetta, et al.
Publicado: (2021)

Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer
por: Bandiera, Elisabetta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o3qar72megog76sq00ok202cr6